Results 201 to 210 of about 355,709 (346)

Clinical utility of endoscopic ultrasound (EUS) guided FNA in the preoperative staging of non-small cell lung cancer (NSCLC) in computerized tomography negative patients

, 2001
Maurits J. Wiersema, Eric S. Edell, David E. Midthun, Mary Lou Jondal, Afonso Ribeiro, Mayo Clin   +5 more
openalex   +1 more source

Usefulness of CT Chest in Determining Clinically Significant Mediastinal Lymphadenopathy in Patients With Non-Small Cell Lung Cancer (NSCLC) [PDF]

, 2003
Mazen Alakhras, Geetha Kanajam, Damodhar Nerella, Karthikeyan Kanagarajan, D. Malli, Kanchan Gupta, Krishnan Padmanabhan   +6 more
openalex   +1 more source

Acetylation-dependent USP7-TRIM25 axis drives oncogenic progression in non-small cell lung cancer. [PDF]

Cell Death Dis
Yang J, Chen Z, Hu W, Zeng W, Lei Z, Tong X, Li Q, Luo G, Hu K, Chen Z, Liu Z, Li C, Xu C, Ding C, Zhang HT, Zhao J.   +15 more
europepmc   +1 more source

Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumors

International Journal of Cancer, EarlyView.
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li, Ziyang Shen, Yuxiang Sun, Pengcheng Zhu, Tongyan Liu, Rong Yin   +5 more
wiley   +1 more source

PCN7: ECONOMIC EVALUATION OF GEMZAR AND BEST SUPPORTIVE CARE (BSC) RELATIVE TO BEST SUPPORTIVE CARE ALONE IN THE TREATMENT OF NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK

, 2001
Jan McKendrick, N. Botwood, M Aristides, M Lees, N Maniadakis, Wolfgang Wein, D. Stephenson   +6 more
openalex   +1 more source

5-Hydroxytryptamine promotes non-small cell lung cancer metastasis via the SNRPG/WT1/CDK14 Axis. [PDF]

Mol Biomed
Sun J, Liu CG, Chen S, Zhou H, Liu X, Wang FR, Luo YW, Zang D, Chen J.   +8 more
europepmc   +1 more source

Novel therapeutic strategy targeting STMN1 using chlorambucil‐conjugated pyrrole–imidazole polyamide in small cell lung cancer

International Journal of Cancer, EarlyView.
What's New? Small cell lung cancer (SCLC) is aggressive and difficult to treat but exhibits high levels of stathmin 1 (STMN1), a candidate therapeutic target. In this study, the authors synthesized a chlorambucil (Chb)‐conjugated pyrrole–imidazole polyamide (PIP) compound targeting the STMN1 promoter and DNA sequences and evaluated its efficacy in ...
Ryohei Yoshikawa, Takayoshi Watanabe, Yoichi Ohtaki, Toshikazu Bando, Hiroshi Sugiyama, Takuya Araki, Hideaki Yashima, Bilguun Erkhem‐Ochir, Haruka Okami, Gendensuren Dorjkhorloo, Ikuma Shioi, Toshiteru Nagashima, Natsuko Kawatani, Tomohiro Yazawa, Eiji Narusawa, Takayuki Kosaka, Osamu Kawashima, Mitsuhiro Kamiyoshihara, John D. Minna, Luc Girard, Ken Shirabe, Hiroki Nagase, Kimihiro Shimizu, Takehiko Yokobori   +23 more
wiley   +1 more source

A blinded prospective study comparing transbronchial needle aspiration (TBNA) and endosonography guided needle aspiration (EUS FNA) in the staging of mediastinal lymphadenopathy (MLN) in patients with non small cell lung cancer (NSCLC)

, 2001

openalex   +1 more source

Ebp1 p48 Promotes Oncogenic Properties in Non-Small Cell Lung Cancer Through PI3K/Akt Signaling Pathways. [PDF]

Onco Targets Ther
Ma L, Wang S, Zhang J, Xin M, Xu D, Liu L, Li X.   +6 more
europepmc   +1 more source

New trend in molecular diagnostics: Insights from the tumor microenvironment

Interdisciplinary Medicine, EarlyView.
The graphical abstract outline the key elements in TME‐based molecular diagnostics, including biomarker exploration, diagnostic methods, and diagnostic models. Source: Created with BioRender.com. Abstract Molecular diagnosis has revolutionized cancer precision medicine.
Baiyuan Fan, Jiahui Zhang, Chong Li, Xu Zhang   +3 more
wiley   +1 more source